scAtria single-cell spatial atlas resource

NSCLC_38242124 · IMC / Imaging Mass Cytometry

NSCLC_38242124 · NSCLC_38242124__IMC

IMC / Imaging Mass Cytometry Spatial proteomics Curated Tiered

Spatial Domain

Download spatial tables

Spatial Domain (Tier 1)

2,069 ready
Sample Organ Disease state Cells Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. Domain share Purity Diversity
NSCLC_38242124__IMC__175_C1,7 Lung Primary cancer 4,101 Tumor/Malignant 59.3% 0.99 0.08
NSCLC_38242124__IMC__175_C1,8 Lung Primary cancer 3,113 Immune 27.8% 0.85 0.42
NSCLC_38242124__IMC__175_C1,9 Lung Primary cancer 3,009 Tumor/Malignant 47.1% 0.99 0.04
NSCLC_38242124__IMC__175_C2,1 Lung Primary cancer 4,243 Tumor/Malignant 46.8% 0.89 0.30
NSCLC_38242124__IMC__175_C2,10 Lung Primary cancer 3,797 Tumor/Malignant 84.8% 0.99 0.03
NSCLC_38242124__IMC__175_C2,11 Lung Primary cancer 2,770 Tumor/Malignant 44.0% 0.92 0.30
NSCLC_38242124__IMC__175_C2,12 Lung Primary cancer 3,309 Tumor/Malignant 82.9% 0.99 0.04
NSCLC_38242124__IMC__175_C2,13 Lung Primary cancer 4,144 Immune 33.7% 0.84 0.38
NSCLC_38242124__IMC__175_C2,14 Lung Primary cancer 2,934 Tumor/Malignant 62.5% 0.97 0.11
NSCLC_38242124__IMC__175_C2,15 Lung Primary cancer 973 Immune 36.2% 0.43 0.85
NSCLC_38242124__IMC__175_C2,16 Lung Primary cancer 7,105 Immune 85.2% 0.98 0.05
NSCLC_38242124__IMC__175_C2,2 Lung Primary cancer 1,267 Tumor/Malignant 24.3% 0.54 0.92
NSCLC_38242124__IMC__175_C2,3 Lung Primary cancer 2,888 Tumor/Malignant 39.1% 0.95 0.20
NSCLC_38242124__IMC__175_C2,4 Lung Primary cancer 3,614 Immune 28.9% 0.42 0.85
NSCLC_38242124__IMC__175_C2,5 Lung Primary cancer 3,120 Tumor/Malignant 39.5% 0.92 0.28
NSCLC_38242124__IMC__175_C2,6 Lung Primary cancer 4,083 Tumor/Malignant 43.1% 0.99 0.05
NSCLC_38242124__IMC__175_C2,7 Lung Primary cancer 2,572 Tumor/Malignant 48.1% 0.97 0.12
NSCLC_38242124__IMC__175_C2,8 Lung Primary cancer 2,498 Tumor/Malignant 66.9% 0.96 0.14
NSCLC_38242124__IMC__175_C2,9 Lung Primary cancer 3,369 Tumor/Malignant 60.8% 0.96 0.13
NSCLC_38242124__IMC__175_C3,1 Lung Primary cancer 2,395 Tumor/Malignant 67.4% 0.95 0.16

Spatial Domain (Tier 2)

2,069 ready
Sample Organ Disease state Cells Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. Domain share Purity Diversity
NSCLC_38242124__IMC__175_C1,7 Lung Primary cancer 4,101 Tumor/Malignant 58.8% 0.99 0.07
NSCLC_38242124__IMC__175_C1,8 Lung Primary cancer 3,113 Tumor/Malignant 21.1% 0.29 1.13
NSCLC_38242124__IMC__175_C1,9 Lung Primary cancer 3,009 Tumor/Malignant 51.8% 0.98 0.07
NSCLC_38242124__IMC__175_C2,1 Lung Primary cancer 4,243 Tumor/Malignant 29.3% 0.69 0.63
NSCLC_38242124__IMC__175_C2,10 Lung Primary cancer 3,797 Tumor/Malignant 85.1% 0.99 0.03
NSCLC_38242124__IMC__175_C2,11 Lung Primary cancer 2,770 Tumor/Malignant 43.8% 0.92 0.29
NSCLC_38242124__IMC__175_C2,12 Lung Primary cancer 3,309 Tumor/Malignant 65.3% 1.00 0.03
NSCLC_38242124__IMC__175_C2,13 Lung Primary cancer 4,144 Lymphoid 27.9% 0.84 0.40
NSCLC_38242124__IMC__175_C2,14 Lung Primary cancer 2,934 Tumor/Malignant 43.6% 0.98 0.08
NSCLC_38242124__IMC__175_C2,15 Lung Primary cancer 973 Lymphoid 27.5% 0.75 0.63
NSCLC_38242124__IMC__175_C2,16 Lung Primary cancer 7,105 Lymphoid 77.8% 1.00 0.03
NSCLC_38242124__IMC__175_C2,2 Lung Primary cancer 1,267 Stromal 24.2% 0.77 0.58
NSCLC_38242124__IMC__175_C2,3 Lung Primary cancer 2,888 Tumor/Malignant 39.2% 0.95 0.20
NSCLC_38242124__IMC__175_C2,4 Lung Primary cancer 3,614 Tumor/Malignant 27.0% 0.49 0.86
NSCLC_38242124__IMC__175_C2,5 Lung Primary cancer 3,120 Tumor/Malignant 35.4% 0.94 0.23
NSCLC_38242124__IMC__175_C2,6 Lung Primary cancer 4,083 Tumor/Malignant 56.1% 0.96 0.15
NSCLC_38242124__IMC__175_C2,7 Lung Primary cancer 2,572 Tumor/Malignant 41.6% 0.99 0.06
NSCLC_38242124__IMC__175_C2,8 Lung Primary cancer 2,498 Tumor/Malignant 49.3% 1.00 0.05
NSCLC_38242124__IMC__175_C2,9 Lung Primary cancer 3,369 Tumor/Malignant 63.0% 0.96 0.14
NSCLC_38242124__IMC__175_C3,1 Lung Primary cancer 2,395 Tumor/Malignant 51.0% 1.00 0.06

Spatial Domain (Tier 3)

2,069 ready
Sample Organ Disease state Cells Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. Domain share Purity Diversity
NSCLC_38242124__IMC__175_C1,7 Lung Primary cancer 4,101 Tumor/Malignant cell 60.4% 0.98 0.09
NSCLC_38242124__IMC__175_C1,8 Lung Primary cancer 3,113 T cell 24.9% 0.34 1.05
NSCLC_38242124__IMC__175_C1,9 Lung Primary cancer 3,009 Tumor/Malignant cell 64.7% 0.95 0.16
NSCLC_38242124__IMC__175_C2,1 Lung Primary cancer 4,243 Tumor/Malignant cell 46.9% 0.89 0.31
NSCLC_38242124__IMC__175_C2,10 Lung Primary cancer 3,797 Tumor/Malignant cell 87.1% 0.99 0.04
NSCLC_38242124__IMC__175_C2,11 Lung Primary cancer 2,770 Tumor/Malignant cell 42.8% 0.92 0.29
NSCLC_38242124__IMC__175_C2,12 Lung Primary cancer 3,309 Tumor/Malignant cell 82.9% 0.99 0.04
NSCLC_38242124__IMC__175_C2,13 Lung Primary cancer 4,144 T cell 32.7% 0.64 0.73
NSCLC_38242124__IMC__175_C2,14 Lung Primary cancer 2,934 Tumor/Malignant cell 62.7% 0.97 0.12
NSCLC_38242124__IMC__175_C2,15 Lung Primary cancer 973 T cell 34.6% 0.48 0.96
NSCLC_38242124__IMC__175_C2,16 Lung Primary cancer 7,105 B cell 85.7% 0.66 0.41
NSCLC_38242124__IMC__175_C2,2 Lung Primary cancer 1,267 Tumor/Malignant cell 23.8% 0.55 0.95
NSCLC_38242124__IMC__175_C2,3 Lung Primary cancer 2,888 Tumor/Malignant cell 45.8% 0.92 0.28
NSCLC_38242124__IMC__175_C2,4 Lung Primary cancer 3,614 Fibroblast 30.3% 0.32 1.10
NSCLC_38242124__IMC__175_C2,5 Lung Primary cancer 3,120 Tumor/Malignant cell 40.4% 0.92 0.29
NSCLC_38242124__IMC__175_C2,6 Lung Primary cancer 4,083 Tumor/Malignant cell 57.4% 0.96 0.17
NSCLC_38242124__IMC__175_C2,7 Lung Primary cancer 2,572 Tumor/Malignant cell 49.5% 0.97 0.13
NSCLC_38242124__IMC__175_C2,8 Lung Primary cancer 2,498 Tumor/Malignant cell 69.1% 0.95 0.15
NSCLC_38242124__IMC__175_C2,9 Lung Primary cancer 3,369 Tumor/Malignant cell 63.6% 0.95 0.15
NSCLC_38242124__IMC__175_C3,1 Lung Primary cancer 2,395 Tumor/Malignant cell 67.3% 0.96 0.16